Increased activity of the Wnt/β-catenin signalling pathway has been observed in osteosarcoma [38,39], and a possible interaction between TRIM37 and β-catenin has been proposed to be involved in the aberrant signalling of this pathway in other cancer types [398]. This evidence concerns the gene TRIM37 and osteosarcoma.